In vitro in-depth characterization of emodepside in combination with key anthelmintic drugs on soil-transmitted helminths
- 1Department of Research, Swiss Tropical and Public Health Institute, Allschwil, Switzerland
- 2University of Basel, Basel, Switzerland
Abstract
Despite the enormous disease burden, treatments are limited for soil-transmitted helminthiasis. The handful of anthelmintic drugs suffer from variable and often insufficient efficacy against the pathogens. Resistance development, caused by high drug pressure, is an ongoing concern. New treatments are needed, and combination therapies may represent a promising therapeutic strategy. We explored emodepside as a partner in combination therapy and characterized drug-interaction effects with key anthelmintics in vitro against different soil-transmitted helminths (STHs). Drug-interaction studies were carried out in human recombinant cytochromes P450 assays. Combination studies revealed species-, stage-, and drug-dependent interaction profiles. For benzimidazole-emodepside combinations, potentiation was only observed against Ancylostoma ceylanicum larvae, while against adult stages, up to threefold potentiation or synergy (ΣFIC < 0.9) was observed for Heligmosomoides polygyrus and Trichuris muris, especially for albendazole and albendazole sulfoxide. Combinations of emodepside with macrocyclic lactones showed mostly strong synergy against H. polygyrus larvae (ΣFIC 0.06–2.52), while other species trended toward antagonism (ΣFIC >1.5). Against adult stages, potentiation or synergism was observed in H. polygyrus and T. muris, while against Strongyloides ratti, only the moxidectin-emodepside combination was synergistic (ΣFIC 0.69–0.99). For nAChR agonists, levamisole showed the strongest effect against Necator americanus larvae, while oxantel pamoate exhibited potentiation or synergistic effects across multiple species and life stages. CYP450 inhibition assays reveal no relevant drug-drug interactions. This study provides a thorough evaluation of emodepside as a combination partner against soil-transmitted helminths in vitro, paving the way for in vivo studies and ultimately a novel combination therapy with emodepside against STH infections.
Related
- Development, field-testing and optimization of tools to quantify soil-transmitted helminths in fecal sludge from school pit latrines in Ethiopia
- Anthelmintic effects of forage chicory (Cichorium intybus) against free-living and parasitic stages of Cooperia oncophora
- Simulated Targeted Anthelmintic Treatment Maintains Dung Removal but Not Dung‐Inhabiting Insect Communities
- Integrative in vitro, in vivo, and in silico investigation with mineral profiling of Combretum indicum: A multi-target therapeutic candidate exhibiting antioxidant, thrombolytic, anti-inflammatory, anti-arthritic, analgesic, cytotoxic, and anthelmintic activities
- Helminths reveal long-term trophic simplification in owl communities
BibTeX
@article{scharer2026vitro,
title = {{In vitro in-depth characterization of emodepside in combination with key anthelmintic drugs on soil-transmitted helminths}},
author = {Anastasia Schärer and Cécile Häberli and Dominique Schlienger and Jennifer Keiser},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
month = oct,
doi = {10.1128/aac.00825-26},
url = {https://doi.org/10.1128/aac.00825-26},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - In vitro in-depth characterization of emodepside in combination with key anthelmintic drugs on soil-transmitted helminths
AU - Anastasia Schärer
AU - Cécile Häberli
AU - Dominique Schlienger
AU - Jennifer Keiser
PY - 2026
DA - 2026/10/08
JO - Antimicrobial Agents and Chemotherapy
DO - 10.1128/aac.00825-26
UR - https://doi.org/10.1128/aac.00825-26
AB - Despite the enormous disease burden, treatments are limited for soil-transmitted helminthiasis. The handful of anthelmintic drugs suffer from variable and often insufficient efficacy against the pathogens. Resistance development, caused by high drug pressure, is an ongoing concern. New treatments are needed, and combination therapies may represent a promising therapeutic strategy. We explored emodepside as a partner in combination therapy and characterized drug-interaction effects with key anthelmintics in vitro against different soil-transmitted helminths (STHs). Drug-interaction studies were carried out in human recombinant cytochromes P450 assays. Combination studies revealed species-, stage-, and drug-dependent interaction profiles. For benzimidazole-emodepside combinations, potentiation was only observed against Ancylostoma ceylanicum larvae, while against adult stages, up to threefold potentiation or synergy (ΣFIC < 0.9) was observed for Heligmosomoides polygyrus and Trichuris muris, especially for albendazole and albendazole sulfoxide. Combinations of emodepside with macrocyclic lactones showed mostly strong synergy against H. polygyrus larvae (ΣFIC 0.06–2.52), while other species trended toward antagonism (ΣFIC >1.5). Against adult stages, potentiation or synergism was observed in H. polygyrus and T. muris, while against Strongyloides ratti, only the moxidectin-emodepside combination was synergistic (ΣFIC 0.69–0.99). For nAChR agonists, levamisole showed the strongest effect against Necator americanus larvae, while oxantel pamoate exhibited potentiation or synergistic effects across multiple species and life stages. CYP450 inhibition assays reveal no relevant drug-drug interactions. This study provides a thorough evaluation of emodepside as a combination partner against soil-transmitted helminths in vitro, paving the way for in vivo studies and ultimately a novel combination therapy with emodepside against STH infections.
SN - 1098-6596
SN - 0066-4804
ER -